Johnson & Johnson JNJ CONTACT LENSES / OTHER — Sales to customers (Note 9)
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Johnson & Johnson in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →
Ask your AI about Johnson & Johnson's contact lenses / other — sales to customers (note 9).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Johnson & Johnson's CONTACT LENSES / OTHER — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported CONTACT LENSES / OTHER — sales to customers (note 9) of $969M in Q1 2026.
- How has Johnson & Johnson's CONTACT LENSES / OTHER — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's CONTACT LENSES / OTHER — sales to customers (note 9) increased by 5.4% year-over-year, from $919M to $969M.
- What is the long-term trend for Johnson & Johnson's CONTACT LENSES / OTHER — sales to customers (note 9)?
- Over 4 years (2021 to 2025), Johnson & Johnson's CONTACT LENSES / OTHER — sales to customers (note 9) has grown at a 3.3% compound annual growth rate (CAGR), from $3.44B to $3.91B.
- What does CONTACT LENSES / OTHER — sales to customers (note 9) mean?
- This metric represents the total net revenue generated from the sale of contact lenses and associated vision care products within a specific reporting period. It serves as a key indicator of the company's market penetration and consumer demand within the vision care segment. Tracking this revenue stream allows investors to evaluate the performance of the company's consumer health and medical device portfolio in the optical market.